Sökning: (WFRF:(Muto Masahiro))
> (2021) >
Rituximab in Membra...
Rituximab in Membranous Nephropathy
-
- Gauckler, Philipp (författare)
- Medical University of Innsbruck,Med Univ Innsbruck, Austria
-
- Shin, Jae Il (författare)
- Severance Hospital,Yonsei University,Yonsei Univ, South Korea; Severance Childrens Hosp, South Korea; Yonsei Univ, South Korea
-
- Alberici, Federico (författare)
- University of Brescia,Spedali Civili Di Brescia,ASST Spedali Civili Brescia, Italy; Univ Brescia, Italy
-
visa fler...
-
- Audard, Vincent (författare)
- Henri Mondor Hospital,University Paris-Est Créteil,Paris East Univ, France
-
- Bruchfeld, Annette (författare)
- Linköpings universitet,Karolinska Institutet,Linköping University,Karolinska Institute,Karolinska University Hospital,Avdelningen för diagnostik och specialistmedicin,Medicinska fakulteten,Region Östergötland, Njurmedicinska kliniken US,Karolinska Univ Hosp, Sweden
-
- Busch, Martin (författare)
- Universitätsklinikum Jena,Friedrich Schiller University Jena,Friedrich Schiller Univ, Germany
-
- Cheung, Chee Kay (författare)
- University Hospitals of Leicester NHS Trust,University of Leicester,Univ Leicester, England; Univ Hosp Leicester NHS Trust, England
-
- Crnogorac, Matija (författare)
- Dubrava University Hospital,Dubrava Univ Hosp, Croatia
-
- Delbarba, Elisa (författare)
- Spedali Civili Di Brescia,ASST Spedali Civili Brescia, Italy
-
- Eller, Kathrin (författare)
- Medical University of Graz,Med Univ Graz, Austria
-
- Faguer, Stanislas (författare)
- Institute of Cardiovascular and Metabolic Diseases (I2MC),Toulouse University Hospital,CHU Toulouse, France; Inst Natl Sante & Rech Med, France
-
- Galesic, Kresimir (författare)
- Dubrava University Hospital,Dubrava Univ Hosp, Croatia
-
- Griffin, Siân (författare)
- University Hospital of Wales,Univ Hosp Wales, Wales
-
- van den Hoogen, Martijn W.F. (författare)
- Erasmus University Medical Center,Erasmus MC Univ Med Ctr Rotterdam, Netherlands,Klinikum Wels Grieskirchen, Austria; Johannes Kepler Univ Linz, Austria
-
- Hrušková, Zdenka (författare)
- General University Hospital in Prague,Charles University in Prague,Charles Univ Prague, Czech Republic; Gen Univ Hosp, Czech Republic
-
- Jeyabalan, Anushya (författare)
- New York Presbyterian Hospital/Columbia University Medical Center,Columbia Univ, NY USA
-
- Karras, Alexandre (författare)
- Hôpital Européen Georges-Pompidou,Hop Europeen Georges Pompidou, France
-
- King, Catherine (författare)
- New Queen Elizabeth Hospital,Univ Hosp Birmingham, England
-
- Kohli, Harbir Singh (författare)
- Postgraduate Institute of Medical Education and Research,Post Grad Inst Med Educ & Res, India
-
- Mayer, Gert (författare)
- Medical University of Innsbruck,Med Univ Innsbruck, Austria
-
- Maas, Rutger (författare)
- Radboud University Medical Center,Radboud Univ Nijmegen Med Ctr, Netherlands
-
- Muto, Masahiro (författare)
- Juntendo University,Juntendo Univ, Japan
-
- Moiseev, Sergey (författare)
- I.M. Sechenov First Moscow State Medical University,Sechenov First Moscow State Med Univ, Russia
-
- Odler, Balazs (författare)
- Medical University of Graz,Med Univ Graz, Austria
-
- Pepper, Ruth J. (författare)
- University College London,Royal Free Hospital,UCL, England
-
- Quintana, Luis F. (författare)
- University of Barcelona,Univ Barcelona, Spain
-
- Radhakrishnan, Jai (författare)
- New York Presbyterian Hospital/Columbia University Medical Center,Columbia Univ, NY USA
-
- Ramachandran, Raja (författare)
- Postgraduate Institute of Medical Education and Research,Post Grad Inst Med Educ & Res, India
-
- Salama, Alan D. (författare)
- University College London,Royal Free Hospital,UCL, England
-
- Schönermarck, Ulf (författare)
- Ludwig-Maximilian University of Munich,University Hospital Munich,Ludwig Maximilians Univ Munchen, Germany
-
- Segelmark, Mårten (författare)
- Lund University,Lunds universitet,Njurmedicin,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Nephrology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Skåne University Hospital,Skane Univ Hosp, Sweden
-
- Smith, Lee (författare)
- Anglia Ruskin University,Anglia Ruskin Univ, England
-
- Tesař, Vladimír (författare)
- Charles University in Prague,General University Hospital in Prague,Charles Univ Prague, Czech Republic; Gen Univ Hosp, Czech Republic
-
- Wetzels, Jack (författare)
- Radboud University Nijmegen,Radboud Univ Nijmegen Med Ctr, Netherlands
-
- Willcocks, Lisa (författare)
- Addenbrooke's Hospital,Cambridge Univ Hosp, England
-
- Windpessl, Martin (författare)
- Klinikum Wels-Grieskirchen,Johannes-Kepler-University of Linz
-
- Zand, Ladan (författare)
- Mayo Clinic Minnesota,Mayo Clin, MN USA
-
- Zonozi, Reza (författare)
- Massachusetts General Hospital,Massachusetts Gen Hosp, MA 02114 USA
-
- Kronbichler, Andreas (författare)
- Medical University of Innsbruck,Med Univ Innsbruck, Austria
-
visa färre...
-
(creator_code:org_t)
-
- Elsevier BV, 2021
- 2021
- Engelska.
-
Ingår i: Kidney International Reports. - : Elsevier BV. - 2468-0249. ; 6:4, s. 881-893
- Relaterad länk:
-
http://dx.doi.org/10... (free)
-
visa fler...
-
http://www.kireports...
-
https://liu.diva-por... (primary) (Raw object)
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
http://kipublication...
-
https://urn.kb.se/re...
-
visa färre...
Abstract
Ämnesord
Stäng
- Membranous nephropathy (MN) is the most common cause of primary nephrotic syndrome among adults. The identification of phospholipase A2 receptor (PLA2R) as target antigen in most patients changed the management of MN dramatically, and provided a rationale for B-cell depleting agents such as rituximab. The efficacy of rituximab in inducing remission has been investigated in several studies, including 3 randomized controlled trials, in which complete and partial remission of proteinuria was achieved in approximately two-thirds of treated patients. Due to its favorable safety profile, rituximab is now considered a first-line treatment option for MN, especially in patients at moderate and high risk of deterioration in kidney function. However, questions remain about how to best use rituximab, including the optimal dosing regimen, a potential need for maintenance therapy, and assessment of long-term safety and efficacy outcomes. In this review, we provide an overview of the current literature and discuss both strengths and limitations of “the new standard.”
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Urologi och njurmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Urology and Nephrology (hsv//eng)
Nyckelord
- B cells
- membranous nephropathy
- nephrotic syndrome
- rituximab
- B cells; membranous nephropathy; nephrotic syndrome; rituximab
Publikations- och innehållstyp
- for (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Gauckler, Philip ...
-
Shin, Jae Il
-
Alberici, Federi ...
-
Audard, Vincent
-
Bruchfeld, Annet ...
-
Busch, Martin
-
visa fler...
-
Cheung, Chee Kay
-
Crnogorac, Matij ...
-
Delbarba, Elisa
-
Eller, Kathrin
-
Faguer, Stanisla ...
-
Galesic, Kresimi ...
-
Griffin, Siân
-
van den Hoogen, ...
-
Hrušková, Zdenka
-
Jeyabalan, Anush ...
-
Karras, Alexandr ...
-
King, Catherine
-
Kohli, Harbir Si ...
-
Mayer, Gert
-
Maas, Rutger
-
Muto, Masahiro
-
Moiseev, Sergey
-
Odler, Balazs
-
Pepper, Ruth J.
-
Quintana, Luis F ...
-
Radhakrishnan, J ...
-
Ramachandran, Ra ...
-
Salama, Alan D.
-
Schönermarck, Ul ...
-
Segelmark, Mårte ...
-
Smith, Lee
-
Tesař, Vladimír
-
Wetzels, Jack
-
Willcocks, Lisa
-
Windpessl, Marti ...
-
Zand, Ladan
-
Zonozi, Reza
-
Kronbichler, And ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Urologi och njur ...
- Artiklar i publikationen
-
Kidney Internati ...
- Av lärosätet
-
Lunds universitet
-
Karolinska Institutet
-
Linköpings universitet